An Inducible, Large-Intestine-Specific Transgenic Mouse Model for Colitis and Colitis-Induced Colon Cancer Research

被引:6
|
作者
Wang, Fa [1 ]
Johnson, Robert L. [2 ,5 ]
Snyder, Paul W. [2 ,3 ,7 ]
DeSmet, Marsha L. [4 ,6 ]
Fleet, James C. [1 ,3 ]
机构
[1] Purdue Univ, Dept Nutr Sci, 700 West State St, W Lafayette, IN 47907 USA
[2] Purdue Univ, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA
[3] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA
[4] Purdue Univ, Interdisciplinary Life Sci PhD Training Program, W Lafayette, IN 47907 USA
[5] Eli Lilly & Co, Lilly Corp Ctr, 355 East Merrill St, Indianapolis, IN 46225 USA
[6] Indiana Univ, Dept Dermatol, Sch Med, 550 N Univ Blvd,Suite 3240, Indianapolis, IN 46202 USA
[7] EPL Inc, 45600 Terminal Dr 100, Sterling, VA 20166 USA
基金
美国国家卫生研究院;
关键词
Colorectal cancer; Transgenic animal model; Cre recombinase; Colitis; COLORECTAL-CANCER; ANIMAL-MODELS; FIELD CANCERIZATION; APC INACTIVATION; STEM-CELLS; EXPRESSION; CARCINOGENESIS; INFLAMMATION; EPITHELIUM; NEOPLASIA;
D O I
10.1007/s10620-015-3971-7
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Animal models are an important tool to understand intestinal biology. Our laboratory previously generated C57BL/6-Tg(Car1-cre)5Flt transgenic mice (CAC) with large-intestine-specific Cre recombinase (Cre) expression as a model to study colon health. To expand the utility of the CAC mouse model by determining the impact of chemically induced colitis on CAC transgene expression. CAC mice were crossed to Rosa reporter mice (Rosa26R (flox/flox) ) with a lox-STOP-lox signal controlling beta-galactosidase (beta gal) expression and then further crossed with Apc(CKO/CKO) mice in some experiments to delete Apc alleles (Apc (Delta 580) ). Initially, 8-week-old CAC(Tg/WT);Rosa26R (flox/WT) ;Apc (Delta 580/WT) mice were treated with dextran sulfate sodium (DSS) in drinking water (5 days, 0, 0.65, 1.35, or 2.0 %). Colon tissue damage and beta gal labeling were analyzed 10 day after stopping DSS. Next, 8-week-old CAC(Tg/WT);Rosa26R(flox/flox) mice were treated with 0 or 1.35 % DSS, and colonic beta gal labeling was assessed at 30 day post-DSS treatment. Finally, 10-week-old CAC(Tg/WT);Apc (Delta 580/WT) mice were treated with DSS (0 or 2 %) for 5 days and colonic tumors were analyzed at 20 weeks. CAC(Tg/WT);Rosa26R (flox/WT) ;Apc (Delta 580/WT) mice had a DSS dose-dependent increase in colon epithelial damage that correlated with increased epithelial beta gal labeling at 10 days (r (2) = 0.9, beta = 0.75). The beta gal labeling in CAC(Tg/WT);Rosa26R(flox/flox) mice colon remained high at 30 days, especially in the crypts of the healed ulcer. DSS also increased colon tumor incidence and multiplicity in CAC(Tg/WT);Apc (Delta 580/WT) mice. DSS-mediated epithelial damage induces a persistent, Cre-mediated recombination of floxed alleles in CAC mice. This enables the examination of gene function in colon epithelium during experimental colitis and colitis-induced colon cancer.
引用
收藏
页码:1069 / 1079
页数:11
相关论文
共 50 条
  • [31] Role of Natural Killer T Cells in the Mouse Colitis-Associated Colon Cancer Model
    Yoshioka, K.
    Ueno, Y.
    Tanaka, S.
    Nagai, K.
    Onitake, T.
    Hanaoka, R.
    Watanabe, H.
    Chayama, K.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2012, 75 (01) : 16 - 26
  • [32] Generation of a Transgenic Mouse for Colorectal Cancer Research with Intestinal Cre Expression Limited to the Large Intestine
    Xue, Yingben
    Johnson, Robert
    DeSmet, Marsha
    Snyder, Paul W.
    Fleet, James C.
    MOLECULAR CANCER RESEARCH, 2010, 8 (08) : 1095 - 1104
  • [33] The effect of enalapril on preventing colon cancer in AOM/DSS-induced colitis-associated colon cancer model and xenograft model
    Han, Y. M.
    Lee, C.
    Lee, J. W.
    Kim, J. H.
    Chun, J.
    Im, J. P.
    Kim, J. S.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S130 - S131
  • [34] Antisecretory effects of neuropeptide Y in the mouse colon are region-specific and are lost in DSS-induced colitis
    Klompus, Matthew
    Ho, Winnie
    Sharkey, Keith A.
    McKay, Derek M.
    REGULATORY PEPTIDES, 2010, 165 (2-3) : 138 - 145
  • [35] Prevention of colitis-associated colon cancer in the dextran sulfate sodium mouse model by oltipraz.
    Clapper, ML
    Cooper, HS
    Flanigan, A
    Tanaka, K
    Chang, WC
    Pfeiffer, GR
    Murthy, S
    GASTROENTEROLOGY, 1999, 116 (04) : A390 - A391
  • [36] Cysteinyl leukotriene receptor 1 facilitates tumorigenesis in a mouse model of colitis-associated colon cancer
    Osman, Janina
    Savari, Sayeh
    Chandrashekar, Naveen Kumar
    Bellamkonda, Kishan
    Douglas, Desiree
    Sjolander, Anita
    ONCOTARGET, 2017, 8 (21) : 34773 - 34786
  • [37] Use of a novel genetic mouse model to investigate the role of folate in colitis-associated colon cancer
    Chapkin, Robert S.
    Kamen, Barton A.
    Callaway, Evelyn S.
    Davidson, Laurie A.
    George, Nysia I.
    Wang, Naisyin
    Lupton, Joanne R.
    Finnell, Richard H.
    JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2009, 20 (08): : 649 - 655
  • [38] The role of invariant natural killer T cells on a mouse colitis-associated colon cancer model
    Yoshioka, Kyoko
    Ueno, Yoshitaka
    Tanaka, Shinji
    Onitake, Toshiko
    Hanaoka, Rie
    Kawamura, Toru
    Hatakeyama, Tsuyoshi
    Shimamoto, Masaru
    Kanno, Masamoto
    Watanabe, Hiromitsu
    Chayama, Kazuaki
    GASTROENTEROLOGY, 2007, 132 (04) : A95 - A95
  • [39] STRESS-INDUCED INFLAMMATORY CHANGES IN THE COLON OF THE COTTON-TOP TAMARIN MODEL FOR SPONTANEOUS COLITIS AND COLON CANCER
    WOOD, JD
    PECK, OC
    SHARMA, HM
    STONEROOK, M
    HERNANDEZ, JI
    RODRIQUEZ, JV
    RODRIQUEZ, MA
    GASTROENTEROLOGY, 1993, 104 (04) : A803 - A803
  • [40] Colon-targeted S100A8/A9-specific peptide systems ameliorate colitis and colitis-associated colorectal cancer in mouse models
    Euni Cho
    Seok-Jun Mun
    Hyo Keun Kim
    Yu Seong Ham
    Woo Jin Gil
    Chul-Su Yang
    Acta Pharmacologica Sinica, 2024, 45 : 581 - 593